SALINE-FILLED BREAST IMPLANT AVAILABILITY SHOULD BE LIMITED
This article was originally published in The Gray Sheet
Executive Summary
SALINE-FILLED BREAST IMPLANT AVAILABILITY SHOULD BE LIMITED to controlled trials, Public Citizen's Health Research Group says in an Aug. 4 petition to FDA. "Pending a final decision by the FDA regarding whether they are sufficiently safe and effective," HRG argues, "any further use of the devices should be limited" to a three-stage clinical protocol similar to that currently in place for silicone gel-filled breast implants.